News

Today marks a major milestone for Origin Sciences with the publication of our latest research in Nature Communications: “Hologenomic analysis of rectal mucus sampling for detection of adenomatous polyps and colorectal cancer.”.

Origin is proud to see The Times highlight the potential of OriCol™, our 90-second triomic test designed to transform bowel cancer assessment and reduce reliance on invasive colonoscopies. The article underscores OriCol™’s ability to spare more than 600,000 people each year from unnecessary procedures.

Origin Sciences is pleased to announce that OriCol™, the innovative sampling device manufactured by TOGL, has successfully achieved CE marking under the European Union Medical Device Regulation (MDR 2017/745).

Origin Sciences announces a series of updates on their journey toward their next stage of growth.

The Palais des Congrès de Paris hosted the Tripartite Colorectal Meeting as part of the European Society of Coloproctology’s (ESCP) 20th Scientific and Annual Conference from 10–12 September.

We’re proud to mark another significant milestone the official opening of our new clinical suite at the Community Diagnostic Centre, Hollinswood House, Telford.

Chief Scientific Officer, Dr. Daniel Wise and Chief Technology Officer, Prof. Andrew Page have both been in demand with speaking invitations from several leading conferences and forums.

Origin Sciences are proud to announce the launch of our groundbreaking TRIOMIC study in partnership with The Shrewsbury and Telford Hospital NHS Trust.

On 4th September, the Royal Institution in London hosted our inaugural Collaborate Conference.